Adamas Announces New Employment Inducement Grant
13 nov. 2020 16h05 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three...
Adamas Reports Third Quarter 2020 Financial Results
05 nov. 2020 16h03 HE
|
Adamas Pharmaceuticals, Inc.
Third quarter 2020 total revenues of $20.2 million, a 45% increase over third quarter 2019 Third quarter 2020 GOCOVRI® product sales of $19.0 million, a 36% increase over third quarter 2019...
Adamas announces settlement agreement of previously disclosed class action litigation
02 nov. 2020 09h25 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020
26 oct. 2020 16h04 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2020 third quarter financial results on Thursday,...
Adamas Announces New Employment Inducement Grant
09 oct. 2020 16h03 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new...
Adamas appoints new Chief Medical Officer, Adrian Quartel, MD
01 oct. 2020 09h15 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas Announces New Employment Inducement Grant
11 sept. 2020 16h04 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted two new...
Adamas presents new post-hoc data analysis for GOCOVRI® in Parkinson’s disease patients with dyskinesia at the 2020 Movement Disorder Society Virtual Congress
11 sept. 2020 09h15 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas to Present at Upcoming HC Wainwright Conference
08 sept. 2020 16h05 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to...
Adamas Appoints Anna Richo to Board of Directors
01 sept. 2020 09h15 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to...